Aldeyra Therapeutics Inc (ALDX)

Aldeyra Therapeutics Inc. experienced notable insider trading activity recently, with CEO Todd C. Brady acquiring shares valued at $836,900 over two transactions. This buying follows a period where the stock price declined 8.4% over ninety days. The company's last earnings report indicated a significant miss on earnings per share expectations.
Ticker: ALDX Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Aldeyra Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Buy 3 Jun 2026
Value US$77,463.82 | Price 64.64 | Shares 60,662 (+19.0%)
Buy 3 Jun 2026
Value US$3,114,534.16 | Price 285.15 | Shares 71,629 (-0.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-05 2026-06-03 B Purchase

President and CEO

Executive Director
60,662 +19.0%
64.64
US$77,464
60,662 +19.0% 64.64 US$77,464
2026-06-05 2026-06-03 B Purchase

President and CEO

Executive Director
71,629 -0.6%
285.15
US$3,114,534
71,629 -0.6% 285.15 US$3,114,534
2026-03-20 2026-03-19 B Purchase Non-Executive Director
26,501 +39.7%
197.23
US$559,269
26,501 +39.7% 197.23 US$559,269
2026-03-19 2026-03-18 B Purchase

Principal Financial Officer

Officer
5,000 +200.0%
1.42
US$7,100
5,000 +200.0% 1.42 US$7,100
2025-08-15 2025-08-13 B Purchase

Principal Financial Officer

Officer
2,500 +inf%
5.30
US$13,250
2,500 +inf% 5.30 US$13,250
2025-08-12 2025-08-12 PrS Proposed sale

Officer

Officer
22,074
5.26
US$116,109
22,074 5.26 US$116,109
2025-08-13 2025-08-11 PlS Planned sale

Chief Development Officer

Officer
22,073 -9.1%
5.15
US$113,713
22,073 -9.1% 5.15 US$113,713
2025-04-07 2025-04-03 S Sale Large shareholder
3,400,000 -36.7%
1.42
US$4,828,000
3,400,000 -36.7% 1.42 US$4,828,000
2024-08-14 2024-08-12 PlS Planned sale

See Remarks

Officer
10,834 -7.9%
4.74
US$51,313
10,834 -7.9% 4.74 US$51,313
2024-08-14 2024-08-12 S Sale

Chief Development Officer

Officer
16,041 -6.3%
4.74
US$75,975
16,041 -6.3% 4.74 US$75,975
2024-08-12 2024-08-12 PrS Proposed sale

Officer

Officer
10,834
5.10
US$55,253
10,834 5.10 US$55,253
2024-08-12 2024-08-12 PrS Proposed sale

Officer

Officer
16,041
5.10
US$81,809
16,041 5.10 US$81,809
2024-04-08 2024-04-05 B Purchase Large shareholder
37,712 +0.4%
4.74
US$178,755
37,712 +0.4% 4.74 US$178,755
2024-04-08 2024-04-04 B Purchase Large shareholder
140,281 +1.5%
4.67
US$655,112
140,281 +1.5% 4.67 US$655,112
2024-04-03 2024-04-03 B Purchase Large shareholder
309,847 +3.5%
4.09
US$1,267,274
309,847 +3.5% 4.09 US$1,267,274
2024-04-03 2024-04-02 B Purchase Large shareholder
186,051 +2.2%
3.44
US$640,015
186,051 +2.2% 3.44 US$640,015
2024-04-03 2024-04-01 B Purchase Large shareholder
8,374 +0.1%
3.25
US$27,216
8,374 +0.1% 3.25 US$27,216
2024-03-12 2024-03-12 PrS Proposed sale

Officer

Officer
11,537
3.16
US$36,502
11,537 3.16 US$36,502
2024-03-12 2024-03-12 S Sale

Chief Development Officer

Officer
11,537 -4.5%
3.16
US$36,503
11,537 -4.5% 3.16 US$36,503
2024-03-12 2024-03-12 S Sale

President and CEO

Executive Director
85,324 -5.5%
3.05
US$260,238
85,324 -5.5% 3.05 US$260,238
2024-03-12 2024-03-11 S Sale

Chief Development Officer

Officer
18,231 -6.7%
3.41
US$62,102
18,231 -6.7% 3.41 US$62,102
2024-03-12 2024-03-11 S Sale

President and CEO

Executive Director
97,914 -5.9%
3.27
US$320,521
97,914 -5.9% 3.27 US$320,521
2024-03-12 2024-03-11 S Sale

See Remarks

Officer
13,201 -9.9%
3.41
US$44,968
13,201 -9.9% 3.41 US$44,968
2024-03-11 2024-03-11 PrS Proposed sale

Officer

Officer
183,238
3.25
US$595,524
183,238 3.25 US$595,524
2024-03-11 2024-03-11 PrS Proposed sale

Officer

Officer
13,201
3.62
US$47,788
13,201 3.62 US$47,788
2024-03-11 2024-03-11 PrS Proposed sale

Officer

Officer
18,231
3.62
US$65,996
18,231 3.62 US$65,996
2023-10-18 2023-10-18 S Sale Large shareholder
306,499 -3.4%
1.74
US$533,308
306,499 -3.4% 1.74 US$533,308
2023-10-18 2023-10-16 S Sale Large shareholder
2,450,000 -21.6%
1.60
US$3,920,000
2,450,000 -21.6% 1.60 US$3,920,000
2024-10-21 2023-04-12 B Purchase Non-Executive Director
509 +123.2%
10.13
US$5,156
509 +123.2% 10.13 US$5,156
2022-08-11 2022-08-10 B Purchase Large shareholder
15,000 +0.1%
7.85
US$117,750
15,000 +0.1% 7.85 US$117,750
2022-08-11 2022-08-09 B Purchase Large shareholder
100,000 +0.9%
7.50
US$750,000
100,000 +0.9% 7.50 US$750,000
2022-08-10 2022-08-08 B Purchase Large shareholder
97,000 +0.9%
7.24
US$702,280
97,000 +0.9% 7.24 US$702,280
2022-08-09 2022-08-05 B Purchase Large shareholder
141,000 +1.3%
6.95
US$979,950
141,000 +1.3% 6.95 US$979,950
2022-08-08 2022-08-04 B Purchase Large shareholder
95,100 +0.9%
6.17
US$586,767
95,100 +0.9% 6.17 US$586,767
2022-08-05 2022-08-03 B Purchase Large shareholder
100,000 +0.9%
5.84
US$584,000
100,000 +0.9% 5.84 US$584,000
2022-08-04 2022-08-02 B Purchase Large shareholder
412,406 +4.0%
5.59
US$2,305,350
412,406 +4.0% 5.59 US$2,305,350
2022-08-03 2022-08-01 B Purchase Large shareholder
144,185 +1.4%
5.05
US$728,134
144,185 +1.4% 5.05 US$728,134
2022-08-02 2022-07-29 B Purchase Large shareholder
222,123 +2.2%
5.03
US$1,117,279
222,123 +2.2% 5.03 US$1,117,279
2022-08-01 2022-07-28 B Purchase Large shareholder
119,392 +1.2%
5.00
US$596,960
119,392 +1.2% 5.00 US$596,960
2022-06-27 2022-06-23 B Purchase

President and CEO

Executive Director
17,700 +1.5%
3.36
US$59,546
17,700 +1.5% 3.36 US$59,546
2022-06-27 2022-06-23 B Purchase Non-Executive Director
4,323 +22.0%
3.48
US$15,025
4,323 +22.0% 3.48 US$15,025
2024-10-21 2021-05-03 B Purchase Non-Executive Director
413 +inf%
12.81
US$5,291
413 +inf% 12.81 US$5,291
2021-05-04 2021-05-03 B Purchase Large shareholder
1,200,000 +13.8%
12.50
US$15,000,000
1,200,000 +13.8% 12.50 US$15,000,000
2021-01-21 2021-01-19 B Purchase Large shareholder
1,368,421 +18.7%
9.50
US$13,000,000
1,368,421 +18.7% 9.50 US$13,000,000
2021-01-11 2021-01-08 B Purchase Large shareholder
50,000 +0.7%
7.60
US$380,000
50,000 +0.7% 7.60 US$380,000
2021-01-11 2021-01-08 B Purchase Large shareholder
152,668 +2.1%
10.21
US$1,558,740
152,668 +2.1% 10.21 US$1,558,740
2021-01-11 2021-01-08 B Purchase Large shareholder
347,332 +5.1%
9.21
US$3,198,928
347,332 +5.1% 9.21 US$3,198,928
2021-01-11 2021-01-07 B Purchase Large shareholder
500,000 +8.0%
8.13
US$4,065,000
500,000 +8.0% 8.13 US$4,065,000
2020-07-13 2020-07-09 B Purchase Large shareholder
3,200,000 +103.7%
4.25
US$13,600,000
3,200,000 +103.7% 4.25 US$13,600,000
2020-03-17 2020-03-16 B Purchase Non-Executive Director
40,000 +47.1%
2.75
US$110,000
40,000 +47.1% 2.75 US$110,000
2019-12-18 2019-12-16 B Purchase Brady Todd C

President and CEO

Executive Director
20,000 +3.2%
5.10
US$101,908
20,000 +3.2% 5.10 US$101,908
2019-10-02 2019-09-30 PP Planned purchase

President and CEO

Executive Director
8,710 +1.4%
5.68
US$49,483
8,710 +1.4% 5.68 US$49,483
2019-09-25 2019-09-23 PP Planned purchase

President and CEO

Executive Director
8,680 +1.4%
5.81
US$50,433
8,680 +1.4% 5.81 US$50,433
2019-09-20 2019-09-18 B Purchase

President and CEO

Executive Director
14,288 +2.4%
5.91
US$84,465
14,288 +2.4% 5.91 US$84,465
2019-09-19 2019-09-17 B Purchase
1,700 +10.0%
5.85
US$9,945
1,700 +10.0% 5.85 US$9,945
2019-09-17 2019-09-16 B Purchase

President and CEO

Executive Director
3,000 +0.5%
6.03
US$18,090
3,000 +0.5% 6.03 US$18,090
2019-09-17 2019-09-13 B Purchase
5,000 +6.2%
6.00
US$30,000
5,000 +6.2% 6.00 US$30,000
2019-09-17 2019-09-13 B Purchase

President and CEO

Executive Director
10,000 +1.7%
5.79
US$57,900
10,000 +1.7% 5.79 US$57,900
2019-09-16 2019-09-12 B Purchase
1,700 +9.5%
5.86
US$9,964
1,700 +9.5% 5.86 US$9,964
2019-09-13 2019-09-12 B Purchase
10,000 +14.3%
6.03
US$60,276
10,000 +14.3% 6.03 US$60,276
2019-09-13 2019-09-11 B Purchase
10,000 +16.7%
5.75
US$57,529
10,000 +16.7% 5.75 US$57,529
2019-09-11 2019-09-10 B Purchase

President and CEO

Executive Director
10,000 +1.8%
5.39
US$53,937
10,000 +1.8% 5.39 US$53,937
2019-09-11 2019-09-10 B Purchase
10,000 +20.0%
5.09
US$50,857
10,000 +20.0% 5.09 US$50,857
2019-09-11 2019-09-09 PP Planned purchase

President and CEO

Executive Director
10,000 +1.8%
4.89
US$48,887
10,000 +1.8% 4.89 US$48,887
2019-09-11 2019-09-09 B Purchase
10,000 +25.0%
4.91
US$49,106
10,000 +25.0% 4.91 US$49,106
2019-09-10 2019-09-06 PP Planned purchase

Chief Medical Officer

5,000 +38.8%
5.06
US$25,311
5,000 +38.8% 5.06 US$25,311
2019-09-09 2019-09-05 PP Planned purchase

Chief Financial Officer

3,200 +9.8%
4.71
US$15,072
3,200 +9.8% 4.71 US$15,072
2019-09-09 2019-09-05 PP Planned purchase

Chief Commerical Officer

4,329 +238.0%
4.68
US$20,260
4,329 +238.0% 4.68 US$20,260
2019-03-28 2019-03-26 S Sale Non-Executive Director
445 -4.8%
10.01
US$4,454
445 -4.8% 10.01 US$4,454
2019-03-28 2019-03-26 S Sale Non-Executive Director
96,298 -4.9%
10.01
US$963,943
96,298 -4.9% 10.01 US$963,943
2017-09-21 2017-09-19 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
200,000 +6.9%
7.25
US$1,450,000
200,000 +6.9% 7.25 US$1,450,000
2017-07-05 2017-06-30 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
296,007 +11.4%
4.60
US$1,361,632
296,007 +11.4% 4.60 US$1,361,632
2017-02-21 2017-02-17 B Purchase Tulipano Stephen J

Chief Financial Officer

3,333 +inf%
4.50
US$14,998
3,333 +inf% 4.50 US$14,998
2017-02-21 2017-02-17 B Purchase JOYCE MARTIN JOSEPH
4,444 +32.9%
4.50
US$19,998
4,444 +32.9% 4.50 US$19,998
2017-02-21 2017-02-17 B Purchase Bronstein Ben
4,444 +35.6%
4.50
US$19,998
4,444 +35.6% 4.50 US$19,998